-
1by Hisashi Yamanaka, Naoyuki Kamatani, Yoshiya Tanaka, Toshihiko Hibino, Edit Drescher, Juan Sánchez-Bursón, Manfred Rettenbacher, Girish Bhatia, Snehal Gadve, Chirag Shah, Dhananjay Bakhle“..., and immunogenicity of YLB113 with the RP over a treatment period of 52 weeks. Methods Overall, 528 patients...”
Published 2019-12-01
Get full text
Article -
2by Maiko Hajime, Yosuke Okada, Hiroko Mori, Fumi Uemura, Satomi Sonoda, Kenichi Tanaka, Akira Kurozumi, Manabu Narisawa, Keiichi Torimoto, Yoshiya Tanaka“... diabetes mellitus (T2DM), using continuous glucose monitoring (CGM). Methods T2DM patients (n = 293...”
Published 2019-02-01
Get full text
Article -
3by Ippei Miyagawa, Kazuhisa Nakano, Shigeru Iwata, Shingo Nakayamada, Kazuyoshi Saito, Kentaro Hanami, Shunsuke Fukuyo, Satoshi Kubo, Akio Kawabe, Yusuke Miyazaki, Yoshiya Tanaka“... of entero-Behcet’s disease (BD). However, there is no objective tool for assessment of disease activity...”
Published 2019-06-01
Get full text
Article -
4by Yoshiya Tanaka, Tsutomu Takeuchi, Hiroyuki Izutsu, Yuichiro Kaneko, Daisuke Kato, Musashi Fukuda, Mitsuhiro Rokuda, Neil M. Schultz“... and an inadequate response to prior disease-modifying antirheumatic drugs (DMARDs). Methods Patients from two...”
Published 2021-08-01
Get full text
Article -
5by Damon Bass, Regina Kurrasch, Yoshiya Tanaka, Sang-Cheol Bae, Beulah Ji, David A Roth, Jenny Lowe, Myron Chu, Paula Curtis, Kathleen DeRose, Paige Meizlik“... lupus erythematosus (SLE) from Japan and South Korea.Methods In this phase III, open-label continuation...”
Published 2021-08-01
Get full text
Article -
6by Yoshiya Tanaka, Hideto Kameda, Kazuyoshi Saito, Yuko Kaneko, Eiichi Tanaka, Shinsuke Yasuda, Naoto Tamura, Keishi Fujio, Takao Fujii, Toshihisa Kojima, Tatsuhiko Anzai, Chikuma Hamada, Yoshihisa Fujino, Shinya Matsuda, Hitoshi Kohsaka“...) with RA in a real-world clinical practice. Methods This multicenter, observational, prospective study...”
Published 2018-07-01
Get full text
Article -
7by Masanobu Ueno, Ippei Miyagawa, Kazuhisa Nakano, Shigeru Iwata, Kentaro Hanami, Shunsuke Fukuyo, Satoshi Kubo, Yusuke Miyazaki, Akio Kawabe, Hiroko Yoshinari, Shingo Nakayamada, Yoshiya Tanaka“... adequately evaluated in real-world clinical practice. In this study, we assessed the effectiveness and safety...”
Published 2021-03-01
Get full text
Article -
8by Yusuke Miyazaki, Shingo Nakayamada, Satoshi Kubo, Yuichi Ishikawa, Maiko Yoshikawa, Kei Sakata, Shigeru Iwata, Ippei Miyagawa, Kazuhisa Nakano, Yoshiya Tanaka“... and the selection criteria for RTX therapy in AAV remain unclear. Methods Phenotypic characterization of circulating...”
Published 2020-06-01
Get full text
Article -
9by Yusuke Miyazaki, Kazuhisa Nakano, Shingo Nakayamada, Satoshi Kubo, Shigeru Iwata, Kentaro Hanami, Shunsuke Fukuyo, Ippei Miyagawa, Ayako Yamaguchi, Akio Kawabe, Kazuyoshi Saito, Yoshiya Tanaka“... and the clinical response to CZP in RA patients in the TSUBAME study. Methods One hundred patients with RA who...”
Published 2021-06-01
Get full text
Article -
10by Yuichi Ishikawa, Shigeru Iwata, Kentaro Hanami, Aya Nawata, Mingzeng Zhang, Kaoru Yamagata, Shintaro Hirata, Kei Sakata, Yasuyuki Todoroki, Kazuhisa Nakano, Shingo Nakayamada, Minoru Satoh, Yoshiya Tanaka“... between hypercytokinemia and lung inflammation in patients with DM RP-ILD. Methods The study subjects were...”
Published 2018-10-01
Get full text
Article -
11by Tsutomu Takeuchi, Hisashi Yamanaka, Masayoshi Harigai, Ryo Tamamura, Yuichi Kato, Yoshifumi Ukyo, Toshikazu Nakano, Benjamin Hsu, Yoshiya Tanaka“... in Japanese patients with RA refractory to methotrexate or sulfasalazine. Methods In this phase 3, double...”
Published 2018-03-01
Get full text
Article -
12by Kei Sakata, Kei Sakata, Shingo Nakayamada, Yusuke Miyazaki, Satoshi Kubo, Akina Ishii, Akina Ishii, Kazuhisa Nakano, Yoshiya Tanaka“...). To assess the precise function of pDCs in SLE patients, we investigated the differential regulation of Toll...”
Published 2018-08-01
Get full text
Article -
13by Sae Ochi, Kazuyoshi Saito, Fumitaka Mizoguchi, Shigeaki Kato, Yoshiya Tanaka“... necrosis factor inhibitors (TNFis), which are the most frequently used bDMARDs. Methods This is a...”
Published 2020-03-01
Get full text
Article -
14by Hideto Kameda, Tsutomu Takeuchi, Kunihiro Yamaoka, Motohiro Oribe, Mitsuhiro Kawano, Masayuki Yokoyama, Aileen L. Pangan, Yuko Konishi, Sebastian Meerwein, Yoshiya Tanaka“... response to conventional synthetic disease-modifying anti-rheumatic drugs. Methods All patients completing...”
Published 2021-01-01
Get full text
Article -
15by Tsutomu Takeuchi, Yoshiya Tanaka, Jay Erdman, Yuichiro Kaneko, Masako Saito, Chieri Higashitani, Ronald Smulders, Christopher Lademacher“... to inhibit human α9 and is currently under investigation for the treatment of RA. Methods This phase 2a...”
Published 2020-10-01
Get full text
Article -
16by Yoshiya Tanaka, Kazuteru Wada, Yoshinori Takahashi, Owen Hagino, Hubert van Hoogstraten, Neil M. H. Graham, Hideto Kameda“.... This bridging study assessed the efficacy and safety of sarilumab + methotrexate (MTX) in Japanese patients...”
Published 2019-03-01
Get full text
Article -
17by Tsutomu Takeuchi, Yoshiya Tanaka, Sakae Tanaka, Atsushi Kawakami, Yeong-Wook Song, Yi-Hsing Chen, Mitsuhiro Rokuda, Hiroyuki Izutsu, Satoshi Ushijima, Yuichiro Kaneko, Yoshihiro Nakashima, Teruaki Shiomi, Emi Yamada“... assessed. Methods This was an interim analysis of an ongoing open-label, multicenter extension study in RA...”
Published 2020-03-01
Get full text
Article